Creation of human cardiac cell sheets using pluripotent stem cells

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 321-327

  Matsuura, Katsuhisa ^a   Wada, Masanori ^b   Shimizu, Tatsuya ^a   Haraguchi, Yuji ^a   Sato, Fumiko ^a   Sugiyama, Kasumi ^a   Konishi, Kanako ^d   Shiba, Yuji ^c   Ichikawa, Hinako ^c   Tachibana, Aki ^b   Ikeda, Uichi ^c   Yamato, Masayuki ^a   Hagiwara, Nobuhisa ^a   Okano, Teruo ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b ABLE Corporation   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d ASAHI KASEI CORPORATION   (Japan)

Author keywords

Bioreactor; Cardiomyocyte; Cell sheet; Human induced pluripotent stem cell

Indexed keywords

CONNEXIN 43; TRANSCRIPTION FACTOR NKX2.5; TRANSGELIN; TROPONIN T;

ARTICLE; BIOREACTOR; CELL CULTURE; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROVASCULATURE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOREACTORS; CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; TISSUE ENGINEERING;

RATTUS;

EID: 84865384458     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.089     Document Type: Article

References (19)

1. Okano T., Yamada N., Sakai H., Sakurai Y. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J. Biomed. Mater. Res. 1993, 27:1243-1251.
2. Kushida A., Yamato M., Konno C., Kikuchi A., Sakurai Y., Okano T. Decrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surfaces. J. Biomed. Mater. Res. 1999, 45:355-362.
3. Matsuura K., Honda A., Nagai T., Fukushima N., Iwanaga K., Tokunaga M., Shimizu T., Okano T., Kasanuki H., Hagiwara N., Komuro I. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J. Clin. Invest. 2009, 119:2204-2217.
4. Memon I.A., Sawa Y., Fukushima N., Matsumiya G., Miyagawa S., Taketani S., Sakakida S.K., Kondoh H., Aleshin A.N., Shimizu T., Okano T., Matsuda H. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J. Thorac. Cardiovasc. Surg. 2005, 130:1333-1341.
5. Sekine H., Shimizu T., Hobo K., Sekiya S., Yang J., Yamato M., Kurosawa H., Kobayashi E., Okano T. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 2008, 118:S145-152.
6. Masumoto H., Matsuo T., Yamamizu K., Uosaki H., Narazaki G., Katayama S., Marui A., Shimizu T., Ikeda T., Okano T., Sakata R., Yamashita J.K. Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization. Stem Cells 2012, 30:1196-1205.
7. Olivetti G., Melissari M., Capasso J.M., Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res. 1991, 68:1560-1568.
8. Shimizu T., Sekine H., Yang J., Isoi Y., Yamato M., Kikuchi A., Kobayashi E., Okano T. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006, 20:708-710.
9. Matsuura K., Masuda S., Haraguchi Y., Yasuda N., Shimizu T., Hagiwara N., Zandstra P.W., Okano T. Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials 2011, 32:7355-7362.
10. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., Henckaerts E., Bonham K., Abbott G.W., Linden R.M., Field L.J., Keller G.M. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
11. Willems E., Spiering S., Davidovics H., Lanier M., Xia Z., Dawson M., Cashman J., Mercola M. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ. Res. 2011, 109:360-364.
12. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
13. Uosaki H., Fukushima H., Takeuchi A., Matsuoka S., Nakatsuji N., Yamanaka S., Yamashita J.K. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 2011, 6:e23657.
14. Burridge P.W., Thompson S., Millrod M.A., Weinberg S., Yuan X., Peters A., Mahairaki V., Koliatsos V.E., Tung L., Zambidis E.T. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011, 6:e18293.
15. Zhang Q., Jiang J., Han P., Yuan Q., Zhang J., Zhang X., Xu Y., Cao H., Meng Q., Chen L., Tian T., Wang X., Li P., Hescheler J., Ji G., Ma Y. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell. Res. 2011, 21:579-587.
16. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10:16-28.
17. Dubois N.C., Craft A.M., Sharma P., Elliott D.A., Stanley E.G., Elefanty A.G., Gramolini A., Keller G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 2011, 29:1011-1018.
18. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.S., Yuasa S., Li W., Yamakawa H., Tanaka T., Onitsuka T., Shimoji K., Ohno Y., Egashira T., Kaneda R., Murata M., Hidaka K., Morisaki T., Sasaki E., Suzuki T., Sano M., Makino S., Oikawa S., Fukuda K. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 2010, 7:61-66.
19. Kita-Matsuo H., Barcova M., Prigozhina N., Salomonis N., Wei K., Jacot J.G., Nelson B., Spiering S., Haverslag R., Kim C., Talantova M., Bajpai R., Calzolari D., Terskikh A., McCulloch A.D., Price J.H., Conklin B.R., Chen H.S., Mercola M. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 2009, 4:e5046.